Person

Jonathan Biller

EVP and Chief Legal Officer, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$7.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 25, 2026VRTXSale945$486.35$460K
Feb 18, 2026VRTXSale1,244$473.68$589K
Feb 17, 2026VRTXSale2,476$489.46$1.2M
Feb 13, 2026VRTXSale988$499.00$493K
Feb 11, 2026VRTXSale1,925$460.43$886K
Dec 3, 2025VRTXSale347$449.00$156K
Oct 2, 2025VRTXSale694$404.21$281K
Feb 18, 2025VRTXSale1,657$455.06$754K
Feb 11, 2025VRTXSale3,433$459.87$1.6M
Oct 2, 2024VRTXSale999$461.66$461K
Feb 12, 2024VRTXSale1,738$418.77$728K
Oct 2, 2023VRTXSale610$346.76$212K

SEC reporting-owner ID (CIK) 1744749 · all filings on EDGAR